Zacks Investment Research Analysis

Acadia Healthcare (ACHC) Tops Q4 Earnings And Revenue Estimates By Zacks Investment Research - Feb 27, 2020

Acadia Healthcare (ACHC) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.47 per share a year ago. These...

Southwestern Energy (SWN) Tops Q4 Earnings Estimates By Zacks Investment Research - Feb 27, 2020

Southwestern Energy (SWN) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.31 per share a year ago. These...

3 Cheap Stocks Under $20 To Buy As The Coronavirus Sends Markets Into A Correction By Zacks Investment Research - Feb 27, 2020

The Dow, the S&P 500, and the Nasdaq all tumbled again Thursday as Wall Street and investors pullback amid coronavirus fears. All three of the major U.S. indexes saw their 2020 gains washed away...

VMware (VMW) Q4 Earnings Lag Estimates By Zacks Investment Research - Feb 27, 2020

VMware (VMW) came out with quarterly earnings of $2.05 per share, missing the Zacks Consensus Estimate of $2.16 per share. This compares to earnings of $1.98 per share a year ago. These figures are...

The Trade Desk (TTD) Surpasses Q4 Earnings And Revenue Estimates By Zacks Investment Research - Feb 27, 2020

The Trade Desk (TTD) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.09 per share a year ago. These...

Occidental Petroleum (OXY) Reports Q4 Loss, Tops Revenue Estimates By Zacks Investment Research - Feb 27, 2020

Occidental Petroleum (OXY) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to earnings of $1.22 per share a year ago. These...

Five Prime Therapeutics (FPRX) Reports Q4 Loss, Misses Revenue Estimates By Zacks Investment Research - Feb 27, 2020

Five Prime Therapeutics (FPRX) came out with a quarterly loss of $0.89 per share versus the Zacks Consensus Estimate of a loss of $0.97. This compares to loss of $1.12 per share a year ago. These...

CytomX Therapeutics (CTMX) Reports Q4 Loss, Lags Revenue Estimates By Zacks Investment Research - Feb 27, 2020

CytomX Therapeutics (CTMX) came out with a quarterly loss of $0.79 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to loss of $0.72 per share a year ago. These figures...

Applied Optoelectronics (AAOI) Reports Q4 Loss, Tops Revenue Estimates By Zacks Investment Research - Feb 27, 2020

Applied Optoelectronics (AAOI) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.02 per share a year ago. These...

All Your Favorite Stocks Are Trading At Discounted Prices By Zacks Investment Research - Feb 27, 2020

The markets are on pace for their worst week since the financial crisis in 2008, and indexes are hitting their lowest levels since October. This correction was needed as the equity market’s...

Acceleron Pharma (XLRN) Reports Q4 Loss, Tops Revenue Estimates By Zacks Investment Research - Feb 27, 2020

Acceleron Pharma (XLRN) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.75 per share a year ago. These figures are...

Gulfport Energy (GPOR) Q4 Earnings And Revenues Lag Estimates By Zacks Investment Research - Feb 27, 2020

Gulfport Energy (GPOR) came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.46 per share a year ago. These...

Sunrun (RUN) Misses Q4 Earnings Estimates By Zacks Investment Research - Feb 27, 2020

Sunrun (RUN) came out with quarterly earnings of $0.10 per share, missing the Zacks Consensus Estimate of $0.27 per share. This compares to loss of $0.05 per share a year ago. These figures are...

Nektar Therapeutics (NKTR) Reports Q4 Loss, Tops Revenue Estimates By Zacks Investment Research - Feb 27, 2020

Nektar Therapeutics (NKTR) came out with a quarterly loss of $0.64 per share versus the Zacks Consensus Estimate of a loss of $0.69. This compares to loss of $0.57 per share a year ago. These figures...

Big Lots (BIG) Lags Q4 Earnings And Revenue Estimates By Zacks Investment Research - Feb 27, 2020

Big Lots (NYSE:BIG) came out with quarterly earnings of $2.39 per share, missing the Zacks Consensus Estimate of $2.53 per share. This compares to earnings of $2.68 per share a year ago. These figures...

Pure Storage (PSTG) Q4 Earnings And Revenues Surpass Estimates By Zacks Investment Research - Feb 27, 2020

Pure Storage (PSTG) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.14 per share a year ago. These figures...

Mylan (MYL) Tops Q4 Earnings Estimates By Zacks Investment Research - Feb 27, 2020

Mylan (NASDAQ:MYL) came out with quarterly earnings of $1.40 per share, beating the Zacks Consensus Estimate of $1.29 per share. This compares to earnings of $1.30 per share a year ago. These figures...